Janus Henderson Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $859M | Sell |
|
|||||
|
2025
Q2 | $764M | Sell |
|
|||||
|
2025
Q1 | $694M | Buy |
|
|||||
|
2024
Q4 | $603M | Buy |
|
|||||
|
2024
Q3 | $625M | Buy |
|
|||||
|
2024
Q2 | $534M | Buy |
|
|||||
|
2024
Q1 | $569M | Sell |
|
|||||
|
2023
Q4 | $503M | Buy |
|
|||||
|
2023
Q3 | $361M | Sell |
|
|||||
|
2023
Q2 | $346M | Buy |
|
|||||
|
2023
Q1 | $379M | Sell |
|
|||||
|
2022
Q4 | $445M | Sell |
|
|||||
|
2022
Q3 | $792M | Buy |
|
|||||
|
2022
Q2 | $359M | Buy |
|
|||||
|
2022
Q1 | $401M | Buy |
|
|||||
|
2021
Q4 | $433M | Sell |
|
|||||
|
2021
Q3 | $518M | Buy |
|
|||||
|
2021
Q2 | $411M | Sell |
|
|||||
|
2021
Q1 | $408M | Buy |
|
|||||
|
2020
Q4 | $502M | Buy |
|
|||||
|
2020
Q3 | $458M | Buy |
|
|||||
|
2020
Q2 | $359M | Buy |
|
|||||
|
2020
Q1 | $210M | Buy |
|
|||||
|
2019
Q4 | $174M | Buy |
|
|||||
|
2019
Q3 | $31.4M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $15.4M | Buy |
|